Table 1 General characteristics of the reviewed studies
From: Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review
| Characteristic | Number | Percentage |
|---|---|---|
| Geography (N = 146) | ||
| North America | 72 | 49 |
| South America | 5 | 3 |
| Europe | 37 | 25 |
| Asia | 20 | 14 |
| Africa | 4 | 3 |
| Middle East | 3 | 2 |
| Australia | 4 | 3 |
| Multi-Region | 1 | 1 |
| Publication Year (N = 146) | ||
| 2000–2002 | 8 | 5 |
| 2003–2005 | 14 | 10 |
| 2006–2008 | 16 | 11 |
| 2009–2011 | 11 | 8 |
| 2012–2014 | 51 | 35 |
| 2015–2017 | 46 | 32 |
| Study Design (N = 146) | ||
| ITS | 16 | 11 |
| Quasi-experimental study | 77 | 53 |
| Retrospective evaluation | 11 | 8 |
| RCT | 14 | 10 |
| Cost-analysis | 10 | 7 |
| Cross-sectional survey | 2 | 1 |
| Observational study | 15 | 10 |
| Unclear | 1 | 1 |
| Number of Beds in Hospital (N = 146) | ||
| < 150 | 13 | 9 |
| 150–500 | 28 | 19 |
| 500–1000 | 41 | 28 |
| > 1000 | 26 | 18 |
| Unclear | 38 | 26 |
| Number of Patients Included (N = 146) | ||
| < 100 | 12 | 8 |
| 100–250 | 20 | 14 |
| 250–500 | 17 | 12 |
| 500–1000 | 5 | 3 |
| 1000–1500 | 8 | 5 |
| > 1500 | 21 | 14 |
| Unclear | 63 | 43 |